Hoth Therapeutics, Inc. (RKTO) AI-Powered Stock Analysis
See how Hoth Therapeutics, Inc. scores across key metrics like financial growth, valuation, and market position using AI-driven evaluation.
RKTO●NASDAQ
HealthcareMedical - Pharmaceuticals
$1.51
$0.46(23.35%)
U.S. Market opens in 53h 10m
Advertisement
Hoth Therapeutics, Inc. (RKTO)
Model Information
The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerHoth Therapeutics, Inc. (RKTO) Stock Overall Grade
Hoth Therapeutics, Inc.’s grade based on a comprehensive AI analysis of financial metrics, growth potential, and market position.
Z
Grade Breakdown by Metric
See how each financial and market factor contributes to Hoth Therapeutics, Inc.'s overall stock rating.
Forecast
C+Score
50/100Financial Growth
CScore
40/100Fundamental Growth
C+Score
56/100Key Ratios
C+Score
55/100Sector Comparison
B+Score
75/100Industry Comparison
C+Score
50/100S&P 500 Benchmark
A+Score
99/100Analyst Consensus
C+Score
50/100Hoth Therapeutics, Inc. (RKTO) AI-Powered Stock Analysis
This asset demonstrates Normal performance with an overall Forecast Score of 50/100 (C+), reflecting weak confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (56/100, C+) highlight its stability, while Key Ratios (55/100, C+) and Sector Comparison (75/100, B+) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (99/100, A+), it shows competitive strength. Analyst Consensus (50/100,C+) suggests High divergence in outlook.Component Analysis Explained
Understand the key factors behind each Hoth Therapeutics, Inc. stock grade, including financials, comparisons, and forecasts.